Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production
about
Recombinant viral capsid protein VP1 suppresses lung cancer metastasis by inhibiting COX-2/PGE2 and MIG-7.The prognostic value of phosphorylated Akt in breast cancer: a systematic review.A matched couple: Combining kinase inhibitors with immunotherapy for cancer treatmentRecombinant protein rVP1 upregulates BECN1-independent autophagy, MAPK1/3 phosphorylation and MMP9 activity via WIPI1/WIPI2 to promote macrophage migration.After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinomaActive form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.PATZ1 induces PP4R2 to form a negative feedback loop on IKK/NF-κB signaling in lung cancer.Chemokines, chemokine receptors and the gastrointestinal system.Autophagy-mediated regulation of macrophages and its applications for cancer.A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2.Deconvoluting the relationships between autophagy and metastasis for potential cancer therapy.The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophagesIL-22 Impedes the Proliferation of Schwann cells: Transcriptome Sequencing and Bioinformatics Analysis.Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer.
P2860
Q33977140-38D29FC4-FD92-49EB-B8CE-0614BCB56BCBQ34925401-384FDCA4-C7A8-4DFA-BD31-F100FF7B83EEQ36038372-192F64B8-C887-44BE-9365-63E98A3E8986Q36524168-2526BFFA-D59F-438C-9FD8-2D9643EDC1D2Q36527253-8620E5CE-9FB6-45A7-9EF9-05D1E94961BEQ37496251-DB05FFA8-B779-4983-B44C-2B188D85DC2EQ37588438-5C72BB26-F59A-4A2D-891B-513883CE24E9Q38109160-80168F1F-AE58-4C78-B818-C08520DFDC5EQ38168389-DCB5CF31-4169-41FD-B80F-6BF1C4D32D32Q38754114-5F09128F-CB5E-494E-8B0D-EBD7C4EEA745Q38784860-EF0869A9-A9C6-4515-BDD2-92232CFFB237Q41481421-36818E19-52B4-4ACC-90E7-5D29B31149A0Q52881492-131FCD56-B2F0-4764-8BFD-F68D71EE7EFDQ54483227-884722C3-3A43-40C9-A937-3B40CD94C29A
P2860
Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@ast
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@en
type
label
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@ast
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@en
prefLabel
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@ast
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@en
P2093
P2860
P1433
P1476
Recombinant VP1, an Akt inhibi ...... modulation of CCL2 production
@en
P2093
Chiao-Li Chu
Jui-Ling Wang
Shao-Wen Hung
Tai-An Chen
Yung-Chih Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0023317
P407
P577
2011-08-03T00:00:00Z